Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Kovalenko

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Advances in Gerontology = Uspekhi Gerontologii|April 20, 2017
[Optimization of treatment of elderly patientswith diabetic foot syndrome and mediakaltsinozom arteries]I Ya Myhaloyko, V D Skrypko, R V Sabadosh, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|September 7, 2013
[Cycloferon in therapy of hyperplastic laryngitis for decrease of the number of relapses]S S Grigorian, M G Romantsov, E V Demchenko, et al.
Klinicheskaia Meditsina|October 27, 2015
[THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS]P S Markevich, L B Markevich, A N Plekhanov, et al.
Angiologiia I Sosudistaia Khirurgiia = Angiology and Vascular Surgery|September 15, 2016
[Pathophysiological and clinical aspects of using L-arginine in cardiology and angiology]V V Valeev, A P Trashkov, A L Kovalenko, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|January 14, 2012
[Induction of endogenous s-adenosyl-l-methionine in hepatocytes during pharmacological correction of experimental acute toxic and chronic drug-induced liver injury]D S Sukhanov, A Iu Petrov, A L Kovalenko, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|August 8, 2018
EXPERIMENTAL ASSESSMENT OF THE SPECIFIC EFFICIENCY OF NEW METABOLIC DRUG RUNIKHOL ON MODELS OF NON-ALCOHOLIC FATTY LIVER DISEASEV V Stel'makh, A P Trashkov, A L Kovalenko, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|June 30, 2010
[Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection]V A Isakov, A L Kovalenko, V V Turkin, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|October 4, 2018
[THE USE OF REMAXOL IN THE TREATMENT OF METABOLIC SYNDROME IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND DIABETES MELLITUS 2 TYPE]S V Dudorenko, A L Kovalenko, S M Prokopenko, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|November 20, 2010
[Effect of hepatoprotector remaxol infusion on liver function in obstructive jaundice model in rats]N G Smirnova, S G Chefu, A L Kovalenko, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|June 4, 2015
[Metabolic therapy of nephrolithiasis in two different rat models of kidney disease]A P Trashkov, A G Vasiliev, A L Kovalenko, et al.
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Advances in Gerontology = Uspekhi Gerontologii|April 20, 2017
[Optimization of treatment of elderly patientswith diabetic foot syndrome and mediakaltsinozom arteries]I Ya Myhaloyko, V D Skrypko, R V Sabadosh, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|September 7, 2013
[Cycloferon in therapy of hyperplastic laryngitis for decrease of the number of relapses]S S Grigorian, M G Romantsov, E V Demchenko, et al.
Klinicheskaia Meditsina|October 27, 2015
[THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS]P S Markevich, L B Markevich, A N Plekhanov, et al.
Angiologiia I Sosudistaia Khirurgiia = Angiology and Vascular Surgery|September 15, 2016
[Pathophysiological and clinical aspects of using L-arginine in cardiology and angiology]V V Valeev, A P Trashkov, A L Kovalenko, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|January 14, 2012
[Induction of endogenous s-adenosyl-l-methionine in hepatocytes during pharmacological correction of experimental acute toxic and chronic drug-induced liver injury]D S Sukhanov, A Iu Petrov, A L Kovalenko, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|August 8, 2018
EXPERIMENTAL ASSESSMENT OF THE SPECIFIC EFFICIENCY OF NEW METABOLIC DRUG RUNIKHOL ON MODELS OF NON-ALCOHOLIC FATTY LIVER DISEASEV V Stel'makh, A P Trashkov, A L Kovalenko, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|June 30, 2010
[Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection]V A Isakov, A L Kovalenko, V V Turkin, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|October 4, 2018
[THE USE OF REMAXOL IN THE TREATMENT OF METABOLIC SYNDROME IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND DIABETES MELLITUS 2 TYPE]S V Dudorenko, A L Kovalenko, S M Prokopenko, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|November 20, 2010
[Effect of hepatoprotector remaxol infusion on liver function in obstructive jaundice model in rats]N G Smirnova, S G Chefu, A L Kovalenko, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|June 4, 2015
[Metabolic therapy of nephrolithiasis in two different rat models of kidney disease]A P Trashkov, A G Vasiliev, A L Kovalenko, et al.
Pageof 13